ASSTON PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Asston Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-5.13₹ -4.88
As on Dec 5, 2025, 4:01 PM IST
Asston Pharmaceuticals Price Performance
Today's LowToday's High
₹90.25₹95.00
₹90.25
52 Weeks' Low52 Weeks' High
₹0.00₹0.00
₹90.25
Open Price
₹94.85
Prev. Close
₹95.13
Volume
9,000
Over the last 5 years, the share price of Asston Pharmaceuticals has declined 6.30% CAGR. Over the past year, the corresponding return has been -27.77%.
Asston Pharmaceuticals’s current P/E of 31.26x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Asston Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Asston Pharmaceuticals | -2.01 | 12.81 | -12.37 | -27.77 | -27.77 | -10.28 | -6.3 |
| Sun Pharmaceutical Industries | -1.43 | 7.07 | 14.21 | 7.44 | 0.01 | 20.27 | 25.39 |
| Divi's Laboratories | -0.17 | -6.07 | 7.34 | -1.27 | 5.52 | 24.3 | 11.72 |
| Torrent Pharmaceuticals | 1.4 | 6.17 | 4.54 | 19.63 | 13.25 | 32.61 | 22.92 |
| Cipla | -0.68 | 1.37 | -1.35 | 1.12 | 2.91 | 10.88 | 14.51 |
| Dr. Reddy's Laboratories | 1.46 | 5.93 | 2.1 | -3.33 | 1.83 | 12.53 | 4.9 |
| Lupin | 0.8 | 7.24 | 7.73 | 4.92 | -1.64 | 39.66 | 16.74 |
| Zydus Lifesciences | -0.97 | -0.34 | -7.54 | -2.8 | -6.2 | 31.21 | 14.6 |
| Mankind Pharma | -2.14 | -4.58 | -14.54 | -6.35 | -14.76 | 15.66 | 9.12 |
| Aurobindo Pharma | -0.7 | 6.56 | 16.83 | 4.71 | -2.45 | 37.65 | 5.94 |
| Alkem Laboratories | 0.31 | 1.03 | 7.18 | 17.21 | 3.56 | 22.31 | 14.31 |
| Abbott India | -4.03 | -2.11 | -6.85 | -9.11 | -0.68 | 12.89 | 13.55 |
| Glenmark Pharmaceuticals | 0.95 | 8.56 | -4.23 | 23.63 | 28.63 | 65.25 | 29.86 |
| Laurus Labs | -0.52 | 4.81 | 14.53 | 59.86 | 74.02 | 34.62 | 25.34 |
| Biocon | -1.36 | 2.03 | 7.84 | 18.99 | 3.4 | 12.07 | -2.7 |
| GlaxoSmithKline Pharmaceuticals | -0.8 | -2.18 | -9.74 | -25.81 | 8.51 | 23.85 | 10.42 |
| Anthem Biosciences | 2.91 | -6.16 | -19.9 | -10.52 | -10.52 | -3.64 | -2.2 |
| Ipca Laboratories | -0.89 | 10.58 | 9.16 | 5.12 | -6.33 | 18.6 | 5.37 |
| Ajanta Pharma | 2.62 | 2.13 | 1.36 | 2.09 | -8.45 | 27.61 | 18.58 |
| Gland Pharma | -0.53 | -7.82 | -6.35 | 6.67 | -3.53 | -0.01 | -5.73 |
Over the last one year, Asston Pharmaceuticals has declined 27.77% compared to peers like Sun Pharmaceutical Industries (0.01%), Divi's Laboratories (5.52%), Torrent Pharmaceuticals (13.25%). From a 5 year perspective, Asston Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (25.39%) and Divi's Laboratories (11.72%).
Asston Pharmaceuticals Financials
Asston Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 97.23 | 96.84 |
| 10 | 92.62 | 94.14 |
| 20 | 86.28 | 90.84 |
| 50 | 90.23 | 92.03 |
| 100 | 93.06 | 0 |
| 200 | 46.53 | 0 |
Asston Pharmaceuticals Share Holding Pattern
In the latest quarter, Asston Pharmaceuticals remained same as its previous close in promoter holding, while DII stake decreased to 0.00%, FII holding fell to 6.04%, and public shareholding moved up to 43.30% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Asston Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 14, 2025, 11:10 PM IST | Asston Pharma - Regulation 30 SEBI (LODR) Regulation Update. |
| Nov 14, 2025, 10:58 PM IST | Asston Pharma - Unaudited Financial Results For The Half Year Ended 30Th September, 2025, Along With A Limited Review Report |
| Nov 14, 2025, 10:49 PM IST | Asston Pharma - Board Meeting Outcome for Outcome Of Board Meeting |
| Nov 11, 2025, 9:11 PM IST | Asston Pharma - Board Meeting Intimation for Intimation Of Board Meeting |
| Oct 17, 2025, 10:32 PM IST | Asston Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Asston Pharmaceuticals
Asston Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/04/2019 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U24304MH2019PTC324187 and registration number is 324187. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 25.04 Cr. and Equity Capital is Rs. 6.27 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address4th Floor, Office No A-431, Balaji Bhavan, Plot No 42A Sector-11, CBD Belapur, Navi Mumbai, Thane Maharashtra 400614
- Contact
Management
- Dr. Ashish Narayan SakalkarManaging Director
- Ms. Saili Jayaram MoreWholeTime Director & CEO
- Mr. Sachin Chandrakant BadakhNon Executive Director
- Mr. Rishabh Kumar JainInd. Non-Executive Director
- Ms. Vijaya ShahpurkarInd. Non-Executive Director
FAQs on Asston Pharmaceuticals Share Price
What is the share price of Asston Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Asston Pharmaceuticals is ₹90.25 as on Dec 05, 2025.
What kind of stock is Asston Pharmaceuticals?
The Asston Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Asston Pharmaceuticals?
The market cap of Asston Pharmaceuticals is ₹76.82 Cr as on Dec 05, 2025.
What are today's High and Low prices of Asston Pharmaceuticals?
Today’s highest and lowest price of Asston Pharmaceuticals are ₹95.00 and ₹90.25.
What are the 52 Week High and 52 Week Low of Asston Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Asston Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Asston Pharmaceuticals is ₹0.00 and 52-week low of Asston Pharmaceuticals is ₹0.00 as on Dec 05, 2025.
How has the Asston Pharmaceuticals performed historically in terms of returns?
The Asston Pharmaceuticals has shown returns of -5.13% over the past day, 12.81% for the past month, -9.75% over 3 months, -27.77% over 1 year, -10.28% across 3 years, and -6.3% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Asston Pharmaceuticals?
P/E ratio of and PB ratio of Asston Pharmaceuticals are 31.26 and 5.93 on Dec 05, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse